PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
European Journal of Cancer Supplements10.1016/s1359-6349(05)80897-3200532168601 ORAL Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysishttps://api.elsevier.com/content/article/PII:S1359634905808973?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905808973?httpAccept=text/plain
Cancer Research and Treatment10.4143/crt.2011.43.3.1542011433154-159Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric CancerHan Jo Kim, Jun Young Eun, Young Woo Jeon, Jina Yun, Kyoung Ha Kim, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Parkhttp://www.e-crt.org/upload/pdf/crt-43-154.pdf, http://www.e-crt.org/upload/pdf/crt-43-154.pdf
Cancer Research and Treatment10.4143/crt.2007.39.3.99200739399Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric CancerIn Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Leehttp://www.e-crt.org/upload/pdf/crt-39-99.pdf, http://www.e-crt.org/upload/pdf/crt-39-99.pdf
Chemotherapy10.1159/0003278402011573230-235Comparison of Cisplatin-5-Fluorouracil-Folinic Acid versus Modified Docetaxel-Cisplatin-5-Fluorouracil Regimens in the First-Line Treatment of Metastatic Gastric CancerF. Tugba Kos, Dogan Uncu, Nuriye Özdemir, Burcin Budakoglu, Hatice Odabaş, Hüseyin Abali, Berna Oksuzoglu, Sercan Aksoy, Nurullah Zenginhttps://www.karger.com/Article/Pdf/327840, http://www.karger.com/Article/Pdf/327840
Cancer Chemotherapy and Pharmacology10.1007/s00280-010-1281-5201067141-48Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trialMatteo Dalla Chiesa, Gianluca Tomasello, Sebastiano Buti, Rodrigo Kraft Rovere, Matteo Brighenti, Silvia Lazzarelli, Gianvito Donati, Rodolfo Passalacquahttp://link.springer.com/content/pdf/10.1007/s00280-010-1281-5.pdf, http://link.springer.com/article/10.1007/s00280-010-1281-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-010-1281-5
European Journal of Cancer Supplements10.1016/s1359-6349(05)80960-7200532188664 PUBLICATION Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)https://api.elsevier.com/content/article/PII:S1359634905809607?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905809607?httpAccept=text/plain
British Journal of Cancer10.1038/sj.bjc.6600204200286111677-1683Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancerD Cunningham, S Falk, D Jacksonhttp://www.nature.com/articles/6600204, http://www.nature.com/articles/6600204.pdf, http://www.nature.com/articles/6600204.pdf
Medical Oncology10.1007/s12032-014-0035-32014317Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancerSong Xie, Guoping Han, Zhikun Fan, Lifeng He, Wenbing Xu, Zhen Qinhttp://link.springer.com/content/pdf/10.1007/s12032-014-0035-3.pdf, http://link.springer.com/article/10.1007/s12032-014-0035-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12032-014-0035-3
European Journal of Cancer Supplements10.1016/s1359-6349(03)90323-5200315S89290 Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancerH. Sørbye, B. Glimelius, Å. Berglund, T. Fokstuen, K.M. Tveit, M. Braedengen, D. Øgreid, O. Dahlhttps://api.elsevier.com/content/article/PII:S1359634903903235?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634903903235?httpAccept=text/plain
Therapeutic Advances in Medical Oncology10.1177/1758834010365061201023161-174Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancerStefan Peinert, Wilfried Grothe, Alexander Stein, Lutz P. Müller, Joern Ruessel, Wieland Voigt, Hans-Joachim Schmoll, Dirk Arnoldhttp://journals.sagepub.com/doi/pdf/10.1177/1758834010365061, http://journals.sagepub.com/doi/pdf/10.1177/1758834010365061